| Literature DB >> 31377227 |
Abstract
Artificial Intelligence (AI) is an area of computer science that simulates the structures and operating principles of the human brain. Machine learning (ML) belongs to the area of AI and endeavors to develop models from exposure to training data. Deep Learning (DL) is another subset of AI, where models represent geometric transformations over many different layers. This technology has shown tremendous potential in areas such as computer vision, speech recognition and natural language processing. More recently, DL has also been successfully applied in drug discovery. Here, I analyze several relevant DL applications and case studies, providing a detailed view of the current state-of-the-art in drug discovery and highlighting not only the problematic issues, but also the successes and opportunities for further advances.Entities:
Mesh:
Year: 2019 PMID: 31377227 DOI: 10.1016/j.drudis.2019.07.006
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851